Appropriate formulation strategies may influence or modify percutaneous characteristics of an active ingredient from a particular preparation.
Several authors have shown that age, diet, hormonal status, comorbidities and other factors may influence and modify the protective potential of ischemic conditioning [ 1, 15, 17, 53].
Although various host factors may influence or modify risk, such as parity [ 14], genetic factors have also been proposed as modifiers of risk, such as genetic variants of HRAS1 [ 15], the androgen receptor (AR) [ 16], the 5'UTR of RAD51 [ 17], and repeat length polymorphisms in AIB1 [ 18], not all of which have been replicated or substantiated in subsequent studies [ 19- 21].
Dietary folate intake and the methylenetetrahydrofolate reductase polymorphism (MTHFR 677C>T) may influence risk by modifying DNA methylation.
Because FN-1 and ITGAV polymorphisms may influence gene expression or modify the biological activities of the functional protein, we set out to test the hypothesis that such polymorphisms influence susceptibility and the severity of knee OA.
Bacteria containing ACC-deaminase in the vicinity of roots may influence plant growth by modifying root architecture through their potential to regulate ethylene synthesis in plant roots.
One could also assume that SDS may influence EDTA adsorption by modifying the charge at the mineral-water interface.
We then examined whether Lad1 may influence the effects of modified calcium levels on EGF-induced ERK5 activation.
Based on these observations, we propose that the way in which PARP-1 recognises DNA may influence whether it is modified by SUMO or not, thus providing a means to delineate two distinct functionalities of the enzyme.
Moreover, they raise the interesting possibility that molecules or conditions (as drugs used for non-tumoral diseases, food components and redox status) that modify AS may influence the response to anti-cancer treatments.
